Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Phenylalpha - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Phenylalpha

Approved

STANDARD

Phenylalpha

Laboratoire Aguettant🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 1d5377f30291ed48
Company: Laboratoire Aguettant
Type: Standard

Approval Details

Approval Id: 1d5377f30291ed48
Drug Approval Philippines Name: Phenylalpha
Product Name: Phenylalpha
Registration Number: DR-XY48056
Brand Name: Phenylalpha
Generic Name: Phenylephrine (as hydrochloride)
Dosage Form: Solution for I.V. Injection
Dosage Strength: 50 mcg/mL (500 mcg/10 mL)
Manufacturer: Laboratoire Aguettant
Importer: The Cathay Drug Co., Inc.
Distributor: The Cathay Drug Co., Inc.
Company Detail Path: /organization/laboratoire-aguettant
Issuance Date: 27 May 2022
Expiry Date: 27 May 2027
Pharmacologic Category: Adrenergic/Dopaminergic Agent
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

1d5377f30291ed48

Type

Standard

Back to Philippines FDA Approvals